euroPLX 51 Limassol 2013
March 4 - 5, 2013
Paphos , Cipro
euroPLX Meetings are the place for pharma deals, attended by industry executives in charge of business development, commercial operations, marketing, and brokers or consultants with clear mandates. euroPLX delivers an average of more than 23 pre-scheduled appointments per participating company.
Partnering scope: Registrants determine the "Dynamic Partnering Focus" of this event. It evolves and changes over time within a range from patented to generic (incl. biosimilars), from prescription to OTC drugs, companion diagnostics, nutraceuticals, and medical devices: development, licensing, marketing, promotion, and distribution.
In addition, attending companies may offer or look for R&D services, supporting technologies (new drug delivery; medical devices), contract manufacture, and, to some extent, the supply of APIs and intermediates.
Partnering scope: Registrants determine the "Dynamic Partnering Focus" of this event. It evolves and changes over time within a range from patented to generic (incl. biosimilars), from prescription to OTC drugs, companion diagnostics, nutraceuticals, and medical devices: development, licensing, marketing, promotion, and distribution.
In addition, attending companies may offer or look for R&D services, supporting technologies (new drug delivery; medical devices), contract manufacture, and, to some extent, the supply of APIs and intermediates.
